Emergent BioSolutions Inc. (NYSE: EBS) announced that, pursuant to the terms of an amended contract with the U.S. Department of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE